{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:07:18Z","timestamp":1791115638977,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"23","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypoxia-inducible factor 1 (HIF-1) is involved in tumor progression\/metastasis and activated in various cancers. Here we show that HIF-1\u03b1, which plays a major role in HIF-1 activation, is overexpressed in preneoplastic hepatocytic lesions from a very early stage during hepatocarcinogenesis in mice and man. Transcriptional targets of HIF-1, such as vascular endothelial growth factor, glut-1, c-met, and insulin-like growth factor II (IGF-II), were also overexpressed in mouse lesions. Oxygen tension within the lesions was not different from that of the normal hepatic tissues, indicating that HIF-1\u03b1 expression was independent of hypoxia. On the other hand, Akt, the pathway of which can up-regulate HIF-1\u03b1 expression, was activated in the mouse lesions, whereas HIF-1\u03b1 was markedly down-regulated in the mouse hepatocellular carcinoma (HCC) cell lines after treatment with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, indicating that HIF-1\u03b1 expression is dependent on PI3K\/Akt signaling. Conversely, HIF-1\u03b1 knockdown by short interfering RNA in the HCC cell line resulted in decreased expression of activated Akt together with the HIF-1 target genes, indicating that Akt activation is reversely dependent on HIF-1 activation. Treating the HCC cells with IGF-II or epidermal growth factor (EGF) up-regulated both phospho-Akt and HIF-1\u03b1, whereas inhibition of IGF-II or EGF signaling down-regulated them both, suggesting that IGF-II and EGF can, at least in part, mediate the activation of Akt and HIF-1\u03b1. However, Akt was not activated by IGF-II or EGF in the HIF-1\u03b1 knockdown cells, indicating that expression of the HIF-1 target genes is necessary for the Akt activation. These findings suggest that the reciprocal activation of PI3K\/Akt signaling and HIF-1\u03b1 may be important in the progression of hepatocarcinogenesis. (Cancer Res 2006; 66(23): 11263-70)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-1699","type":"journal-article","created":{"date-parts":[[2006,12,4]],"date-time":"2006-12-04T17:52:48Z","timestamp":1165254768000},"page":"11263-11270","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Hypoxia-Independent Overexpression of Hypoxia-Inducible Factor 1\u03b1 as an Early Change in Mouse Hepatocarcinogenesis"],"prefix":"10.1158","volume":"66","author":[{"given":"Hiroki","family":"Tanaka","sequence":"first","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Miyakoshi","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Tamakawa","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Yoshie","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Tokusashi","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"2National Hospital Organization, Dohoku National Hospital, Asahikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yaginuma","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Asahikawa Medical College and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,12,4]]},"reference":[{"key":"2022061622104558000_B1","unstructured":"Ishak KG, Goodman ZD, Stocker JT. Tumours of the liver and intrahepatic bile ducts. In: Atlas of tumor pathology, third series fascicle 31. Washington (DC): Armed Forces Institure of Pathology; 2001. p. 185\u201398."},{"key":"2022061622104558000_B2","doi-asserted-by":"crossref","unstructured":"Farber E. The step-by-step development of epithelial cancer: from phenotype to genotype. Adv Cancer Res\u20081996; 70: 21\u201348.","DOI":"10.1016\/S0065-230X(08)60870-2"},{"key":"2022061622104558000_B3","doi-asserted-by":"crossref","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer\u20082003; 3: 721\u201332.","DOI":"10.1038\/nrc1187"},{"key":"2022061622104558000_B4","doi-asserted-by":"crossref","unstructured":"Tanimoto K, Makino Y, Pereira T, Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1\u03b1 by the von Hippel-Lindau tumor suppressor protein. EMBO J\u20082000; 19: 4298\u2013309.","DOI":"10.1093\/emboj\/19.16.4298"},{"key":"2022061622104558000_B5","doi-asserted-by":"crossref","unstructured":"Ohh M, Park CW, Ivan M, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the \u03b2-domain of the von Hippel-Lindau protein. Nat Cell Biol\u20082000; 2: 423\u20137.","DOI":"10.1038\/35017054"},{"key":"2022061622104558000_B6","doi-asserted-by":"crossref","unstructured":"Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature\u20081999; 399: 271\u20135.","DOI":"10.1038\/20459"},{"key":"2022061622104558000_B7","doi-asserted-by":"crossref","unstructured":"Kamura T, Sato S, Iwai K, et al. Activation of HIF1\u03b1 ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A\u20082000; 97: 10430\u20135.","DOI":"10.1073\/pnas.190332597"},{"key":"2022061622104558000_B8","doi-asserted-by":"crossref","unstructured":"Gray MJ, Zhang J, Ellis LM, et al. HIF-1\u03b1, STAT3, CBP\/p300 and Ref-1\/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene\u20082005; 24: 3110\u201320.","DOI":"10.1038\/sj.onc.1208513"},{"key":"2022061622104558000_B9","unstructured":"Jiang BH, Agani F, Passaniti A, Semenza GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res\u20081997; 57: 5328\u201335."},{"key":"2022061622104558000_B10","doi-asserted-by":"crossref","unstructured":"Chan DA, Sutphin PD, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1\u03b1. J Biol Chem\u20082002; 277: 40112\u20137.","DOI":"10.1074\/jbc.M206922200"},{"key":"2022061622104558000_B11","doi-asserted-by":"crossref","unstructured":"Zundel W, Schindler C, Haas-Kogan D, et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev\u20082000; 14: 391\u20136.","DOI":"10.1101\/gad.14.4.391"},{"key":"2022061622104558000_B12","doi-asserted-by":"crossref","unstructured":"Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1\u03b1. Genes Dev\u20082000; 14: 34\u201344.","DOI":"10.1101\/gad.14.1.34"},{"key":"2022061622104558000_B13","doi-asserted-by":"crossref","unstructured":"Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem\u20082002; 277: 38205\u201311.","DOI":"10.1074\/jbc.M203781200"},{"key":"2022061622104558000_B14","doi-asserted-by":"crossref","unstructured":"Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol\u20082001; 21: 3995\u20134004.","DOI":"10.1128\/MCB.21.12.3995-4004.2001"},{"key":"2022061622104558000_B15","unstructured":"Zhong H, Chiles K, Feldser D, et al. Modulation of hypoxia-inducible factor 1\u03b1 expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res\u20082000; 60: 1541\u20135."},{"key":"2022061622104558000_B16","doi-asserted-by":"crossref","unstructured":"Huang GW, Yang LY, Lu WQ. Expression of hypoxia-inducible factor 1\u03b1 and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J Gastroenterol\u20082005; 11: 1705\u20138.","DOI":"10.3748\/wjg.v11.i11.1705"},{"key":"2022061622104558000_B17","doi-asserted-by":"crossref","unstructured":"Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol\u20082000; 157: 411\u201321.","DOI":"10.1016\/S0002-9440(10)64554-3"},{"key":"2022061622104558000_B18","unstructured":"Schirmacher P, Held WA, Yang D, et al. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res\u20081992; 52: 2549\u201356."},{"key":"2022061622104558000_B19","doi-asserted-by":"crossref","unstructured":"Ishizaki T, Yoshie M, Yaginuma Y, Tanaka T, Ogawa K. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions. J Biol Chem\u20082003; 278: 6222\u20138.","DOI":"10.1074\/jbc.M207627200"},{"key":"2022061622104558000_B20","doi-asserted-by":"crossref","unstructured":"Tanno S, Ogawa K. Abundant TGF\u03b1 precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis\u20081994; 15: 1689\u201394.","DOI":"10.1093\/carcin\/15.8.1689"},{"key":"2022061622104558000_B21","unstructured":"Vesselinovitch SD, Mihailovich N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res\u20081983; 43: 4253\u20139."},{"key":"2022061622104558000_B22","doi-asserted-by":"crossref","unstructured":"Yoshie M, Nishimori H, Lee GH, Ogawa K. High colony forming capacity of primary cultured hepatocytes as a dominant trait in hepatocarcinogenesis-susceptible and resistant mouse strains. Carcinogenesis\u20081998; 19: 1103\u20137.","DOI":"10.1093\/carcin\/19.6.1103"},{"key":"2022061622104558000_B23","doi-asserted-by":"crossref","unstructured":"Paine-Murrieta GD, Taylor CW, Curtis RA, et al. Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol\u20081997; 40: 209\u201314.","DOI":"10.1007\/s002800050648"},{"key":"2022061622104558000_B24","unstructured":"Frith CH, Ward JM. A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J Environ Pathol Toxicol\u20081979; 3: 329\u201351."},{"key":"2022061622104558000_B25","doi-asserted-by":"crossref","unstructured":"Chapman JD, Franko AJ, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer\u20081981; 43: 546\u201350.","DOI":"10.1038\/bjc.1981.79"},{"key":"2022061622104558000_B26","doi-asserted-by":"crossref","unstructured":"Arteel GE, Thurman RG, Yates JM, Raleigh JA. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer\u20081995; 72: 889\u201395.","DOI":"10.1038\/bjc.1995.429"},{"key":"2022061622104558000_B27","doi-asserted-by":"crossref","unstructured":"Yamamoto M, Tamakawa S, Yoshie M, Yaginuma Y, Ogawa K. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis. Mol Carcinog. In press 2006.","DOI":"10.1002\/mc.20204"},{"key":"2022061622104558000_B28","doi-asserted-by":"crossref","unstructured":"Miller BS, Yee D. Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res\u20082005; 65: 10123\u20137.","DOI":"10.1158\/0008-5472.CAN-05-2752"},{"key":"2022061622104558000_B29","unstructured":"Feldser D, Agani F, Iyer NV, et al. Reciprocal positive regulation of hypoxia-inducible factor 1\u03b1 and insulin-like growth factor 2. Cancer Res\u20081999; 59: 3915\u20138."},{"key":"2022061622104558000_B30","unstructured":"Kim KW, Bae SK, Lee OH, et al. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res\u20081998; 58: 348\u201351."},{"key":"2022061622104558000_B31","doi-asserted-by":"crossref","unstructured":"Tucci M, Nygard K, Tanswell BV, et al. Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. J Endocrinol\u20081998; 157: 13\u201324.","DOI":"10.1677\/joe.0.1570013"},{"key":"2022061622104558000_B32","doi-asserted-by":"crossref","unstructured":"Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res\u20082003; 284: 2\u201313.","DOI":"10.1016\/S0014-4827(02)00105-2"},{"key":"2022061622104558000_B33","doi-asserted-by":"crossref","unstructured":"Mandriota SJ, Turner KJ, Davies DR, et al. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell\u20082002; 1: 459\u201368.","DOI":"10.1016\/S1535-6108(02)00071-5"},{"key":"2022061622104558000_B34","doi-asserted-by":"crossref","unstructured":"Bos R, Zhong H, Hanrahan CF, et al. Levels of hypoxia-inducible factor-1\u03b1 during breast carcinogenesis. J Natl Cancer Inst\u20082001; 93: 309\u201314.","DOI":"10.1093\/jnci\/93.4.309"},{"key":"2022061622104558000_B35","doi-asserted-by":"crossref","unstructured":"Acs G, Zhang PJ, McGrath CM, et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol\u20082003; 162: 1789\u2013806.","DOI":"10.1016\/S0002-9440(10)64314-3"},{"key":"2022061622104558000_B36","doi-asserted-by":"crossref","unstructured":"Jiang YA, Fan LF, Jiang CQ, et al. Expression and significance of PTEN, hypoxia-inducible factor-1\u03b1 in colorectal adenoma and adenocarcinoma. World J Gastroenterol\u20082003; 9: 491\u20134.","DOI":"10.3748\/wjg.v9.i3.491"},{"key":"2022061622104558000_B37","doi-asserted-by":"crossref","unstructured":"Zhong H, Semenza GL, Simons JW, De Marzo AM. Up-regulation of hypoxia-inducible factor 1\u03b1 is an early event in prostate carcinogenesis. Cancer Detect Prev\u20082004; 28: 88\u201393.","DOI":"10.1016\/j.cdp.2003.12.009"},{"key":"2022061622104558000_B38","unstructured":"Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM. Coordinate up-regulation of hypoxia inducible factor (HIF)-1\u03b1 and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res\u20082000; 60: 6189\u201395."},{"key":"2022061622104558000_B39","doi-asserted-by":"crossref","unstructured":"Mayer A, Wree A, Hockel M, et al. Lack of correlation between expression of HIF-1\u03b1 protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res\u20082004; 64: 5876\u201381.","DOI":"10.1158\/0008-5472.CAN-03-3566"},{"key":"2022061622104558000_B40","doi-asserted-by":"crossref","unstructured":"Zhong H, Mabjeesh N, Willard M, Simons J. Nuclear expression of hypoxia-inducible factor 1\u03b1 protein is heterogeneous in human malignant cells under normoxic conditions. Cancer Lett\u20082002; 181: 233\u20138.","DOI":"10.1016\/S0304-3835(02)00053-8"},{"key":"2022061622104558000_B41","doi-asserted-by":"crossref","unstructured":"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev\u20082004; 18: 1926\u201345.","DOI":"10.1101\/gad.1212704"},{"key":"2022061622104558000_B42","doi-asserted-by":"crossref","unstructured":"De Benedetti A, Graff JR. eIF-4E expression and its role in malignancies and metastases. Oncogene\u20082004; 23: 3189\u201399.","DOI":"10.1038\/sj.onc.1207545"},{"key":"2022061622104558000_B43","unstructured":"Jiang BH, Jiang G, Zheng JZ, et al. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ\u20082001; 12: 363\u20139."},{"key":"2022061622104558000_B44","doi-asserted-by":"crossref","unstructured":"Duan C, Xu Q. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol\u20082005; 142: 44\u201352.","DOI":"10.1016\/j.ygcen.2004.12.022"},{"key":"2022061622104558000_B45","doi-asserted-by":"crossref","unstructured":"Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH, Melillo G. Hypoxic induction of an HIF-1\u03b1-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood\u20082006; 107: 2705\u201312.","DOI":"10.1182\/blood-2005-09-3541"},{"key":"2022061622104558000_B46","doi-asserted-by":"crossref","unstructured":"Li J, Shworak NW, Simons M. Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1\u03b1-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites. J Cell Sci\u20082002; 115: 1951\u20139.","DOI":"10.1242\/jcs.115.9.1951"},{"key":"2022061622104558000_B47","doi-asserted-by":"crossref","unstructured":"Pennacchietti S, Michieli P, Galluzzo M, et al. Hypoxia promotes invasive growth by transcriptional activation of the met proto-oncogene. Cancer Cell\u20082003; 3: 347\u201361.","DOI":"10.1016\/S1535-6108(03)00085-0"},{"key":"2022061622104558000_B48","doi-asserted-by":"crossref","unstructured":"Hayashi M, Sakata M, Takeda T, et al. Up-regulation of c-met proto-oncogene product expression through hypoxia-inducible factor-1\u03b1 is involved in trophoblast invasion under low-oxygen tension. Endocrinology\u20082005; 146: 4682\u20139.","DOI":"10.1210\/en.2005-0416"},{"key":"2022061622104558000_B49","doi-asserted-by":"crossref","unstructured":"LeCouter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science\u20082003; 299: 890\u20133.","DOI":"10.1126\/science.1079562"},{"key":"2022061622104558000_B50","doi-asserted-by":"crossref","unstructured":"Tacchini L, Dansi P, Matteucci E, Desiderio MA. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis\u20082001; 22: 1363\u201371.","DOI":"10.1093\/carcin\/22.9.1363"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/23\/11263\/2557317\/11263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/23\/11263\/2557317\/11263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:47:46Z","timestamp":1655423266000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/23\/11263\/526556\/Hypoxia-Independent-Overexpression-of-Hypoxia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":50,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2006,12,4]]},"published-print":{"date-parts":[[2006,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-1699","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}